Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Literature
1.
Popp AW, Zysset PK, Lippuner K (2016) Rebound-associated vertebral fractures after discontinuation of denosumab—from clinic and biomechanics. Osteoporos Int 27:1917–1921CrossRefPubMed
2.
Lamy O, Gonzalez-Rodriguez E, Stoll D, Hans D, Aubry-Rozier B (2016) Severe rebound-associated vertebral fractures after denosumab discontinuation: nine clinical cases report. J Clin Endocrinol Metab jc20163170
3.
Shepherd JA, Schousboe JT, Broy SB, Engelke K, Leslie WD (2015) Executive summary of the 2015 ISCD position development conference on advanced measures from DXA and QCT: fracture prediction beyond BMD. J Clin Densitom 18:274–286CrossRefPubMed
4.
Bauer DC (2011) Discontinuation of odanacatib and other osteoporosis treatments: here today and gone tomorrow? J Bone Miner Res 26:239–241CrossRefPubMed
Metadata
Title
Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures
Authors
T. Lehmann
D. Aeberli
Publication date
01-10-2017
Publisher
Springer London
Published in
Osteoporosis International / Issue 10/2017
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-017-4108-y

Other articles of this Issue 10/2017

Osteoporosis International 10/2017 Go to the issue

Letter

Osteoporosis exercise knowledge and education in medicine and nursing

Review

Sideways fall-induced impact force and its effect on hip fracture risk: a review

Original Article

Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users

Original Article

Intake of omega-3 fatty acids contributes to bone mineral density at the hip in a younger Japanese female population

Original Article

Network based subcellular proteomics in monocyte membrane revealed novel candidate genes involved in osteoporosis

Original Article

Abdominal obesity and risk of hip fracture: a meta-analysis of prospective studies